Does MEZIGDOMIDE Cause Plasma cell myeloma refractory? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Plasma cell myeloma refractory have been filed in association with MEZIGDOMIDE. This represents 25.0% of all adverse event reports for MEZIGDOMIDE.
7
Reports of Plasma cell myeloma refractory with MEZIGDOMIDE
25.0%
of all MEZIGDOMIDE reports
1
Deaths
6
Hospitalizations
How Dangerous Is Plasma cell myeloma refractory From MEZIGDOMIDE?
Of the 7 reports, 1 (14.3%) resulted in death, 6 (85.7%) required hospitalization, and 6 (85.7%) were considered life-threatening.
Is Plasma cell myeloma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEZIGDOMIDE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MEZIGDOMIDE Cause?
Infection (11)
Pneumonia (11)
Covid-19 (10)
Off label use (8)
Delirium (6)
Neutropenia (6)
Pyrexia (6)
What Other Drugs Cause Plasma cell myeloma refractory?
BORTEZOMIB (618)
DEXAMETHASONE (513)
LENALIDOMIDE (489)
DARATUMUMAB (404)
CARFILZOMIB (386)
POMALIDOMIDE (280)
CYCLOPHOSPHAMIDE (237)
IXAZOMIB (132)
DOXORUBICIN (115)
ETOPOSIDE (90)